Professor Anna Nowak is a medical oncologist, clinical triallist and tumour immunology researcher with a focus on the cancer mesothelioma. She developed the first measurement criteria specific to the unique growth pattern of mesothelioma, which are used in clinical trials worldwide. Professor Nowak was an early investigator of chemo-immunotherapy combinations in the laboratory, advancing our understanding of synergy between these treatments. She has subsequently progressed this work to a number of human clinical trials of chemo-immunotherapy, with a recent efficacious combination progressing through to an international randomised clinical trial.

Professor Nowak is currently Pro Vice Chancellor (Health and Medical Research) at UWA.